drugset / Trial / NCT00222170
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
Phase 2
Completed
24 enrolled
University of Kansas
Eisai Inc. · collabPriCara, Unit of Ortho-McNeil, Inc. · collab
Non-randomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine the production of mucin in GERD/RE subjects before and after 8 weeks of treatment with rabeprazole.
Timeline
- Start
- 2005-05
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabeprazole | Small molecule | 20 mg | — |